MADISON GROBERG: Open Payments
NPI 1043837404 · LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 19 payments from 9 companies in 2025. Trend: 2023 $421 · 2024 $350 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| ABBVIE INC. | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| JAZZ PHARMACEUTICALS INC. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Corium, LLC | 2 | $8 |
Products named: REXULTI, CAPLYTA, VRAYLAR, AUSTEDO XR, XYWAV, FANAPT, INVEGA SUSTENNA, Azstarys.
Industry payments across UT — which companies pay providers there.
